The secondary outcomes of this study included the incidence of, incidence of cardiac arrest (CA), incidence of gastrointestinal adverse reaction, incidence of death from any cause, incidence of revascularization, incidence of infection, hs-CRP, left ventricular ejection fraction (LVEF), IL-6, infarct size, and neutrophil count. This evidence concerns the gene IL6 and cardiac arrest.